Member Login

News

Article Filters

Search
News Categories
News Categories

Patients the big winners out of the election budget 2025-2026. GBMA welcomes ‘cheaper medicines’ measure

Learn more

Hip pocket relief, faster patient access and more patients treated. The GBMA releases its 2025-2026 Pre budget submission

Learn more

Australians to benefit from a potential $1 billion biosimilar medicines’ funding windfall

Learn more

Global Biosimilars Week (GBW) to highlight the health and financial benefits of biosimilar medicines for Australian patients

Learn more

Global Biosimilars Week 2024 to Focus on Advancing Access to Biosimilars

Learn more

Peak body for affordable medicines continues its membership expansion

Learn more

Health decision makers headline at GBMA’s signature Federal Budget event

Learn more

Cost of living at the heart of the Federal Budget Patients to benefit: GBMA

Learn more

The 2024 GBMA Board – New appointments at a time of significant reform of Australia’s medicine policy

Learn more

IGBA announces leadership change

Learn more

IGBA’s Annual Global Biosimilars Week Focuses on Oncology Care

Learn more

Neo Health joins GBMA under new membership tier

Learn more

GBMA welcomes Teva Pharma to its growing membership base

Learn more

New member, Pearce IP, shares GBMA mission to secure access to affordable medicines

Learn more

Federal Budget 2023: patient benefits at the centre of healthcare reforms

Learn more

Thank you for visiting our website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements.

Further information relevant to the Australian environment is available from the Australian Government, Department of Health.

Please click “Continue” to leave this website and proceed to the selected site.

Cancel
Continue